AIP.NASDAQArteris, INC

Form 4: Arteris Director Raman Chitkara Acquires 20,839 Restricted Stock Units

Sentiment:

Insider Transaction Report


Arteris, Inc. Director Raman Chitkara has acquired 20,839 restricted stock units, increasing his beneficial ownership to 157,867 shares.

Summary

  • Raman Chitkara, a Director of Arteris, Inc. (AIP), acquired 20,839 shares of common stock on June 3, 2025.
  • The acquired shares are in the form of Restricted Stock Units (RSUs) granted at a price of $0.00.
  • Following this transaction, Mr. Chitkara's total beneficial ownership in Arteris, Inc. is 157,867 shares.
  • The RSUs will vest in full on the earlier of the first anniversary of the grant date or immediately before the annual meeting of the Issuer's stockholders following the grant date, subject to Mr. Chitkara continuing to provide services to the Issuer's Board through such vesting date.
  • The reporting person elected to defer the receipt of shares from these RSUs.

Sentiment

Score: 7

Explanation: The acquisition of Restricted Stock Units by a director is generally viewed positively as it aligns management's interests with shareholders, indicating confidence in the company's future performance. However, it's a routine compensation event rather than a significant strategic announcement.

Positives

  • Director Raman Chitkara's acquisition of 20,839 Restricted Stock Units (RSUs) aligns his interests with those of shareholders, as the value of these units is tied to the company's stock performance.
  • The grant of RSUs at a $0.00 price indicates an equity-based compensation, which is a common practice to incentivize long-term commitment and performance from board members.

Future Outlook

The vesting schedule for the acquired Restricted Stock Units (RSUs) indicates a future commitment from Director Raman Chitkara, with full vesting contingent on his continued service to the Issuer's Board until the earlier of the first anniversary of the grant date or the annual meeting following the grant date.

Industry Context

This Form 4 filing details an insider transaction, which is a routine disclosure for public companies. It does not provide information on broader industry trends or competitive landscape, focusing solely on changes in beneficial ownership for a specific director.

Related Party Transactions

  • The grant of 20,839 Restricted Stock Units (RSUs) to Director Raman Chitkara represents a standard equity compensation arrangement between the company and a related party (director).

Stakeholder Impact

  • Shareholders may view the RSU grant to a director as a positive sign of alignment between management and shareholder interests, potentially fostering long-term value creation.

Next Steps

  • The vesting of the 20,839 Restricted Stock Units (RSUs) will occur on the earlier of the first anniversary of the grant date (June 3, 2026) or immediately before the annual meeting of the Issuer's stockholders following the grant date, contingent on Director Raman Chitkara's continued service.

Key Dates

DateDescription
06/03/2025Date of acquisition of 20,839 Restricted Stock Units (RSUs) by Director Raman Chitkara.
06/05/2025Date the Form 4 filing was signed by Paul Alpern, Attorney-in-Fact for Raman Chitkara.
On or before 06/03/2026Potential vesting date for the RSUs (first anniversary of the grant date), subject to continued service.
Prior to next annual meetingAlternative potential vesting date for the RSUs (immediately before the annual meeting of stockholders following the grant date), subject to continued service.

Keywords

Arteris, AIP, Form 4, insider transaction, restricted stock units, RSU, director, beneficial ownership, equity compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.